Technical Analysis for SEOVF - Sernova Corp

Grade Last Price % Change Price Change
grade D 0.1507 2.66% 0.0039
SEOVF closed up 2.66 percent on Monday, August 19, 2019, on 2 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical SEOVF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Wide Bands Range Expansion 2.66%
Gapped Up Strength 2.66%
Narrow Range Bar Range Contraction 6.35%
Wide Bands Range Expansion 6.35%
Gapped Down Weakness 6.35%
Oversold Stochastic Weakness 6.35%
Narrow Range Bar Range Contraction 5.02%

Older signals for SEOVF ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Sernova Corp. is a clinical stage regenerative medicine company developing cell therapy based medical technologies for the treatment of chronic debilitating diseases such as diabetes, blood disorders including hemophilia and other diseases all of which are treated through replacement of proteins or hormones missing or in short supply within the body. Sernova is developing the Cell Pouch(TM), a scalable, implantable medical device which forms a vascularized organ-like environment for the transplantation of its locally immune-protected therapeutic cells (self-cells, donor cells, ethically sourced stem cell derived therapeutic cells or xenogeneic cells) which then release proteins and/or hormones as required by the body. The objective of the company's products is to disrupt the standard of care treatments for these serious diseases to improve efficacy, significantly improve patient quality of life and to decrease the severe debilitating disease effects that progress with the standard of care treatments. The product to treat diabetes involves implantation of a small biocompatible medical device under the skin into which are placed immune protected cells which connect to the blood vessel supply to read blood sugar levels and release insulin accordingly, replacing the metabolic function of the pancreas. For hemophelia the cells would release the required protein, Factor VIII on a constant basis reducing or eliminating the need for frequent infusions of Factor VIII.
Biotechnology Branches Of Biology Biology Diabetes Diseases Regenerative Medicine Cell Biology Cell Therapy Transplantation Blood Cloning Developmental Biology Stem Cell Serious Diseases Hemophilia Blood Disorders Cell Encapsulation Diabetes Mellitus Type 1
Is SEOVF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.4043
52 Week Low 0.1089
Average Volume 18,722
200-Day Moving Average 0.1682
50-Day Moving Average 0.1674
20-Day Moving Average 0.1591
10-Day Moving Average 0.1466
Average True Range 0.0086
ADX 12.94
+DI 43.1177
-DI 38.0597
Chandelier Exit (Long, 3 ATRs ) 0.1822
Chandelier Exit (Short, 3 ATRs ) 0.1604
Upper Bollinger Band 0.1886
Lower Bollinger Band 0.1296
Percent B (%b) 0.36
BandWidth 37.083595
MACD Line -0.0072
MACD Signal Line -0.0058
MACD Histogram -0.0014
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.1507
Resistance 3 (R3) 0.1507 0.1507 0.1507
Resistance 2 (R2) 0.1507 0.1507 0.1507 0.1507
Resistance 1 (R1) 0.1507 0.1507 0.1507 0.1507 0.1507
Pivot Point 0.1507 0.1507 0.1507 0.1507 0.1507
Support 1 (S1) 0.1507 0.1507 0.1507 0.1507 0.1507
Support 2 (S2) 0.1507 0.1507 0.1507 0.1507
Support 3 (S3) 0.1507 0.1507 0.1507
Support 4 (S4) 0.1507